Research Sample Repository for Cellular Therapies

This is an observational study creating a research sample repository. It collects blood samples from people involved in hematopoietic cell transplantation (HCT), other cellular therapies, or those with marrow toxic injuries. The goal is to make these samples available for research studies related to histocompatibility (how well donor and recipient tissues match) and the outcomes of these treatments. Researchers will use these samples to understand genetic factors, evaluate treatment success, and study tissue types in different populations. You may be eligible if you are donating hematopoietic cells or other cellular therapy products to an allogeneic (different person) recipient, or if you are a recipient of these therapies, or a patient with marrow toxic injury. The study is ongoing, and the exact recruitment status is unclear.

Study design
This is an observational study with a very large planned enrollment, collecting samples for future research.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Not specified.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT04920474

Protocol for a Research Sample Repository for Hematopoietic Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries

Recruiting
Not specifiedAll AgesObservational
Center for International Blood and Marrow Transplant Research
~99,999,999 participants
Updated 2023-05-03 on ClinicalTrials.gov

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
To make blood samples available for research studies related to histocompatibility and HCT or other cellular therapy
Measured over pre-HCT (recipient) or pre-donation (donor)
Autologous Stem Cell Transplantation
Allogeneic Stem Cell Transplantation
Cellular Therapy
Marrow Toxic Injury
1 sites across 1 states
Minnesota1
  • Stephen Spellman · PRINCIPAL_INVESTIGATOR · NMDP Be The Match/CIBMTR

Opens a ready-to-send draft in your own email app — review before sending.

  • To make blood samples available for research studies related to histocompatibility and HCT or other cellular therapypre-HCT (recipient) or pre-donation (donor)